BackMolecular Pharmacology (USA), Overview

Molecular Pharmacology (USA), Receivables

Latest receivables for MLPH: $7.3K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$7327.00
↑ 35.11% YoYΔ $1904.00 vs prior year quarter

Peer trimmed avg / median

Loading

Molecular Pharmacology (USA), Receivables History

Loading

Molecular Pharmacology (USA), vs. peers: Receivables Comparison

Loading

Molecular Pharmacology (USA), Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Molecular Pharmacology (USA), (MLPH) FAQ

Molecular Pharmacology (USA), (MLPH) currently reports a receivables of $7.3K as of September 2014. That compares with $5.4K in the prior-year period — up 35.1% year over year. Use the charts on this page to explore Molecular Pharmacology (USA),'s receivables history and peer comparisons.

Molecular Pharmacology (USA),'s receivables increased from $5.4K to $7.3K — a 35.1% year-over-year increase (period ending September 2014). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Molecular Pharmacology (USA), reported $7.3K in receivables as of September 2014. That compares with $5.4K in the prior-year period — up 35.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $7.3K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Molecular Pharmacology (USA),, and consider following MLPH for alerts when major investors trade the stock.